The company conducts business under Healthcare sector and is part of Biotechnology industry. On a scale of 0 to 100, PDS Biotechnology holds a performance score of 5. The company holds a Beta of -0.4937, which implies possible diversification benefits within a given portfolio. Let's try to break down what PDS Biotechnology's beta means in this case. As returns on the market increase, returns on owning PDS Biotechnology are expected to decrease at a much lower rate. During the bear market, PDS Biotechnology is likely to outperform the market. Although it is vital to follow PDS Biotechnology current trending patterns, it is good to be conservative about what you can do with the information regarding equity existing price patterns. The approach into forecasting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. We have found twenty-seven technical indicators for PDS Biotechnology, which you can use to evaluate the performance of the company. Please employ PDS Biotechnology expected short fall, and the relationship between the value at risk and daily balance of power to make a quick decision on whether PDS Biotechnology historical price patterns will revert.